Purchase Order 75N98026P01148
Award Date 7/31/26
Potential Completion Date 7/30/27
Potential Value $23K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,825 purchase order to Biovision Technologies, Inc. of Bethesda, Maryland for PIEZO Z TOP PLATE. The firm fixed price contract runs from November 28, 2023 through January 15, 2024 for delivery of the specified product to the agency location in Bethesda. No additional details were provided regarding the original solicitation, use of the product within National Cancer Institute...
- <p>The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, on February 6, 2020, for a high-resolution camera for an existing microscope, with a ceiling value of $12,468.00. Work is performed in Exton, Pennsylvania, with an ultimate completion date of February 5, 2021. The order carries firm fixed pricing.</p>
- Biovision Technologies, Inc. has been awarded a $12,245 purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to deliver a XY-axis linear encoder option for X and Y stages. The encoder will have a resolution of 10 nanometers and will be identified as product LIN-ENCODER. Place of performance will be Biovision's facility located in Exton, Pennsylvania. The firm fixed price order is for a period of performance starting on August...
- <p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for system maintenance services valued at $152,280.00, effective July 19, 2026. The order covers a one-year period of performance through July 18, 2027 and carries a firm fixed-price structure with no small business set-aside. Work is performed in Bethesda, Maryland. The contract references quote HGO061126-01 and maintains an ultimate completion date of July 18, 2031.</p>
- <p>The National Cancer Institute awarded a purchase order to Hamamatsu Corp for $19,110 on July 1, 2026, with final completion due June 30, 2027. The order covers product WSICO-4322-000 under service line S60-EXTWAR-GOLD NDP-S60-000453, referencing quote QUO-67377-V1G0K4. Work is performed in Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside.</p>
- This firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Biovision Technologies, Inc., a small business. The $104,850 contract is for the provision of six diode laser lines and a laser merge system to support the NCI's Center for Cancer Research, Laboratory of Cellular and Molecular Biology. This specialized equipment will be integrated with the government's existing CSU-22 confocal system to enhance its...
- The National Cancer Institute issued a delivery order to Government Scientific Source Inc., a small business, on September 15, 2020, with a ceiling value of $202,169.12 under the GSA Multiple Award Schedule (MAS) for the purchase of two Keyence BZ-X810 all-in-one fluorescence microscopes and associated instrumentation in support of the ETIB and CPTR labs at the NCI Center for Cancer Research. Place of performance is Reston, VA. The order carries a total small business set-aside designation and...
- <p>The National Cancer Institute awarded a purchase order to Hamamatsu Corp for $16,055.00 on May 18, 2026, under firm fixed-price terms with an ultimate completion date of May 17, 2027. No set-aside applied. Place of performance is Bethesda, Maryland. The source does not identify the specific items or equipment being procured under this order.</p>
- <p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>
- The National Cancer Institute issued a purchase order to Government Scientific Source Inc., a small business, on February 21, 2020, for one IncuCyte S3 HD 2CLR live-cell analysis system at a ceiling value of $107,993.00 under a total small business set-aside. The system supports the National Cancer Institute's Center for Cancer Research, Laboratory of Genitourinary Cancer. Place of performance is Reston, Virginia. The order was firm fixed price and carries an ultimate completion date of May 5,...
The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, valued at $22,564.00 on July 31, 2026 for a Tokai Hit Stagetop Control system for temperature, humidity, and CO2 monitoring (Product ID STXG-GSI2X-SET), including Biovision installation services. The order carries a total small business set-aside. Place of performance is Bethesda, Maryland. Ultimate completion is July 30, 2027. The procurement references Quote 070726-1 JP and is priced on a firm fixed-price basis.
Generated 7/30/26, 11:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.6k | 7/28/26 |